Related Experiment Videos
D2 receptor genes--the cause or consequence of substance abuse?
Trends in Neurosciences
|February 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
SCH 39166, a potential antipsychotic drug, does not evoke movement disorders in cebus monkeys.
Neurochemistry international·1992
Effect of SCH 39166, a novel dopamine D1 receptor antagonist, on [3H]acetylcholine release in rat striatal slices.
European journal of pharmacology·1992
Selective up-regulation of D-1 dopamine receptors following chronic administration of SCH 39166 in primates.
Pharmacology, biochemistry, and behavior·1992
[3H]SCH 39166, a new D1-selective radioligand: in vitro and in vivo binding analyses.
Journal of neurochemistry·1991
In vivo binding of SCH 39166: a D-1 selective antagonist.
The Journal of pharmacology and experimental therapeutics·1991
Effects of [N-(L-(1-carboxy-2-phenyl)ethyl]-L-phenylalanyl-beta-alanine (SCH32615), a neutral endopeptidase (enkephalinase) inhibitor, on levels of enkephalin, encrypted enkephalins and substance P in cerebrospinal fluid and plasma of primates.
The Journal of pharmacology and experimental therapeutics·1991
Beyond Bayesian integration: how meaning shapes placebo effects.
Trends in neurosciences·2026
Putting endocrine signaling on the neurodevelopmental map.
Trends in neurosciences·2026
Development sculpts dense neural circuits to enhance memory capacity.
Trends in neurosciences·2026
Alternative splicing dysregulation in CAG repeat expansion diseases.
Trends in neurosciences·2026
An epigenetic view of anxiety disorders, one cell type at a time.
Trends in neurosciences·2026
Fronto-striatal molecular convergence in eating and obsessive-compulsive disorders.
Trends in neurosciences·2026
Multiple binding modes underlie Cannabis sativa cannabinoids recognition by peroxisome proliferator-activated receptor gamma.
Frontiers in bioinformatics·2026
Revisiting multicomponent Doebner and Povarov quinoline synthesis for modern-day drug-discovery.
Organic & biomolecular chemistry·2026
Salvinorin A in humans: A systematic review of pharmacokinetics, pharmacodynamics, and safety.
Journal of psychopharmacology (Oxford, England)·2026
Organic photosensitizers for antifungal therapy: structural diversity and emerging applications.
Chemical communications (Cambridge, England)·2026